A recent roundtable discussion focused on how today's healthcare leaders can "begin to dismantle the systems that perpetuate inequities in medicine and build new systems that promote diversity, equity and inclusive excellence."

Spectrum Laboratory Products is voluntarily recalling the lots after customer complaints found the adrenaline to be discolored.

After Moderna leadership revealed plans to potentially quadruple the price of its COVID-19 vaccine, Sen. Bernie Sanders (D-VT) and others criticized the move.

HHS is moving forward with drug price negotiations afforded to CMS under the Inflation Reduction Act.

Healthcare organizations are under threat from a rapid increase in ransomware attacks, putting patient health information at risk.

CVS Health Ventures, the corporate venture capital arm for the retail pharmacy giant, has invested $100 million into Carbon Health, a “hybrid” primary care services provider.

CVS Health is exploring a sale of Oak Street Health, a primary care provider for Medicare patients, in a deal that could fetch $10 billion. The news was first reported by Bloomberg.

Welcome to Movers and Shakers, a roundup of the latest executive movements in the healthcare industry, featuring leadership changes at Rite Aid and Oak Street Health.

New York City nurses went on strike on Jan. 9 after contract negotiations between workers and two major hospitals collapsed over the weekend.

The U.S. Food and Drug Administration (FDA) approved a new drug treatment for Alzheimer’s disease, Leqembi (lecanemab).